BreastScreen NSW has recommenced operations across Southern NSW Local Health District following a temporary suspension of services.
Services across NSW were gradually paused in response to the risk posed by the COVID-19 Delta strain and a need to redeploy staff to support the pandemic response at each local health district. Services will gradually reopen across the state as local circumstances allow.
BreastScreen NSW will be contacting women who had their appointments cancelled during the temporary suspension as a priority.
BreastScreen NSW (Greater Southern) Designated Radiographer, Bronwyn Morley, said women who had their appointments cancelled should wait to be contacted before calling the service.
“We are asking the community to be patient as we work through our priority bookings. Please hold off on contacting us unless you have received an invitation to screen,” Mrs Morley said.
“Our staff are working tirelessly to ensure women can rebook their life-saving breast screen as soon as possible.”
BreastScreen NSW services have recommenced at its clinics in Queanbeyan, Moruya and Bega.
Mobile clinics will be visiting Crookwell (until 22 October), Goulburn (25 October – 17 December) and Braidwood (29 November – 10 December).
BreastScreen NSW has implemented COVID-19 safe measures at its clinics and mobile screening vans to protect women, staff and the wider community. It is now mandatory for all NSW Health staff to be double vaccinated by Tuesday 30 November 2021.
BreastScreen NSW requires all clients to wear a mask to their appointment. To ensure adequate physical distancing, we request that clients attend their screening appointment alone.
If you feel unwell with symptoms associated with COVID-19 prior to your appointment, please stay at home and contact BreastScreen to reschedule your appointmentNSW Health advises anyone experiencing COVID-19 symptoms to get tested immediately and self-isolate until you receive your results.
We continue to urge any women experiencing breast symptoms to see their regular doctor without delay to get a referral for diagnostic testing, which continues to be the nationally recommended pathway for symptomatic women.